Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Coppo

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Leukemia|May 8, 2009
STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphomaP Coppo, V Gouilleux-Gruart, Y Huang, et al.
Cell Death & Disease|October 10, 2014
Viability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser727C Capron, K Jondeau, L Casetti, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 2, 2020
Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control studyN Lerolle, M Laanani, L Galicier, et al.
La Revue De Medecine Interne|August 6, 2020
[Acquired angioedema due to C1-inhibitor deficiency: CREAK recommendations for diagnosis and treatment]D Gobert, L Bouillet, G Armengol, et al.
Leukemia|May 22, 2013
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphomaA Bouchekioua, L Scourzic, O de Wever, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA groupE Tchernonog, P Faurie, P Coppo, et al.
Cell Death & Disease|October 5, 2012
CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse modelY Zhang, S Patel, H Abdelouahab, et al.
Scandinavian Journal of Immunology|September 11, 2008
Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activityS Malak, M Wolf, G A Millot, et al.
Journal of Crohn'S & Colitis|March 13, 2020
Prognosis of Lymphoma in Patients With Known Inflammatory Bowel Disease: A French Multicentre Cohort StudyT Severyns, J Kirchgesner, J Lambert, et al.
British Journal of Haematology|December 24, 2005
Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpuraP Coppo, M Wolf, A Veyradier, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Leukemia|May 8, 2009
STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphomaP Coppo, V Gouilleux-Gruart, Y Huang, et al.
Cell Death & Disease|October 10, 2014
Viability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser727C Capron, K Jondeau, L Casetti, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 2, 2020
Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control studyN Lerolle, M Laanani, L Galicier, et al.
La Revue De Medecine Interne|August 6, 2020
[Acquired angioedema due to C1-inhibitor deficiency: CREAK recommendations for diagnosis and treatment]D Gobert, L Bouillet, G Armengol, et al.
Leukemia|May 22, 2013
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphomaA Bouchekioua, L Scourzic, O de Wever, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA groupE Tchernonog, P Faurie, P Coppo, et al.
Cell Death & Disease|October 5, 2012
CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse modelY Zhang, S Patel, H Abdelouahab, et al.
Scandinavian Journal of Immunology|September 11, 2008
Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activityS Malak, M Wolf, G A Millot, et al.
Journal of Crohn'S & Colitis|March 13, 2020
Prognosis of Lymphoma in Patients With Known Inflammatory Bowel Disease: A French Multicentre Cohort StudyT Severyns, J Kirchgesner, J Lambert, et al.
British Journal of Haematology|December 24, 2005
Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpuraP Coppo, M Wolf, A Veyradier, et al.
Pageof 7